Dr Priya Sammani ( MBBS ,DFM )It’s a moment many of my patients describe with a bit of a jolt. You go in for a routine check-up, maybe some blood tests for something else entirely, and then you get a call. #bonemarrowbiopsy #Mprotein #multiplemyelomaprecursor #plasmacells #SMM #SmolderingMultipleMyeloma #watchfulwaiting
cancergraceNormal plasma cells are a type of white blood cell that helps make up your immune system. They are located within the bone marrow - the spongy interior of bones that produces blood cells. When your body is fighting an infection, plasma cells produce antibodies (proteins) that attack viruses and bacteria. 🦠💉
If a plasma cell becomes cancerous, it multiplies rapidly. This is multiple myeloma. ⚠️🩸
#MutipleMyeloma #PlasmaCells #Myeloma #WhiteBloodCells #BoneMarrow #CancerGlossary #cancerGRACE
Dom SommaGreat thread!
#Bcells #plasmacells
@Plasmacellguy https://fediscience.org/@Plasmacellguy/111385717686213576
Mohamed ElTanbouly (@Plasmacellguy@fediscience.org)
Attached: 1 image 1/ B cells and plasma cells Where do I start? Is it at Von Behring and Kitasato who were the first to discover that immunization of animals with diptheria and tetanus toxins resulted in soluble substances in the serum that neutralize these same toxins in vitro and make them harmless? https://bit.ly/VonBehring1890
Technische Universität MünchenResearchers discovered a mechanism which provides indications of when and why cells become aggressive and cause #MultipleMyeloma. These findings could help with future #pharmaceutical development: http://go.tum.de/450805
#PlasmaCells #CancerResearch
📷toeytoey2530/iStock
Possible therapeutic approach to fight incurable blood cancer
Multiple myeloma (MM) is the second most common type of blood cancer. It attacks the plasma cells in the blood. A team at the Technical University of Munich (TUM) has now discovered a mechanism which provides indications of when and why these cells become aggressive. The team is still conducting basic research; in the future their findings could also help in the development of medications. Multiple myeloma is today still considered incurable, with survival prognoses for victims averaging only about five years.